Moreover, HDAC6 inhibitor Tubastatin A was found to suppress fibrosis and inflammation in hypertensive mice [15] and attenuate renal tubular damage in acute kidney injury [16], this suggests that HDAC inhibition has beneficial effects in renal fibrosis (Supplementary Figure 1). Here, HDAC6 is linked to renal fibrosis.